3 Dividends To Avoid Now

It’s no secret why most people buy retire on $500,000 (or less!) .

If you’re a reader of my service , none of this will surprise you. The service’s portfolio boasts funds yielding all the way up to 12.9%.

But there is one thing you should know about the CEF market: investors who buy CEFs are a bit twitchy, meaning they can sometimes oversell in a crisis. This is why there are still plenty of great CEF bargains out there (I’ll give you access to my 4 best CEF buys for 9.4%+ dividends at the end of this article).

The flipside is that these folks also have a tendency to pile into certain CEFs when markets climb, making some funds overbought, boasting high premiums to net asset value, or NAV (another way of saying their market prices far exceed the value of their portfolios).

Buying at a big premium is a recipe for steep losses, even if you’re buying a top-quality fund with strong management. That’s exactly the case with the three CEFs I want to talk to you about today.

When I say these three funds are well-managed, I’m not kidding: two of them have some of the highest annualized returns of all CEFs; one was the highest-performing CEF of all time before the coronavirus crisis hit its portfolio. And even with the virus’s effect, that fund has racked up an 11% annualized return over the past decade.

But that aside, they are all overpriced, which slashes their odds of hitting those heights again in the near term. So go ahead and put them on your watch list now—but definitely not your buy list.

The PIMCO Corporate & Income Strategy Fund (NYSE:PCN) yields 8.5% and has returned an incredible 11% annualized, thanks to its portfolio of high-yield corporate bonds and complex debt derivatives. These are the kind of assets PIMCO is very good at managing (and most individual investors are, to be honest, pretty bad at managing on their own!).

Unfortunately, junk bonds have been struggling to make a full recovery, as the coronavirus crisis forces several risky firms into bankruptcy. That’s why PCN’s portfolio is still down double-digits from the start of the year, even as the broader stock market has almost fully recovered.

Get The News You Want

Read market moving news with a personalized feed of stocks you care about.

Get The App

This wouldn’t be so bad if investors were compensated for the risk, but they aren’t anymore.

h3 Premium to Discount … to Premium Again/h3

PCN’s premium has come back with a vengeance, meaning it’s now as pricey as it was before the pandemic hit. That kind of pricing makes no sense given the increased risk involved with PCN’s assets.

h3 Overbought CEF No. 2: A 9.9% Dividend … at a 30% Premium!?/h3

Our next fund, the 9.9%-paying PIMCO Corporate & Income Opportunity Fund (NYSE:PTY), is a close relative to PCN and has given investors a 10.6% annualized return over the last decade. At one time, PCN was the best long-term performer in the CEF universe. Unfortunately, the COVID-19 crisis and selloff reversed that trend, depressing both its NAV and its market price.

h3 Another Big Pandemic Loss/h3

Considering PTY’s portfolio is very similar to that of PCN, this isn’t surprising. Nor is it surprising that PCN’s premium has returned in full, just like PTY’s has.

h3 Another Pre-Pandemic Premium Returns/h3

Will these funds’ discounts return soon? If we see another steep market selloff, it’s likely—and that makes these funds great opportunities when they’re cheap, but not worth the risk when they’re overbought.

h3 Overbought CEF No. 3: A Risky Fund in a (Normally) Safe Sector/h3

The third fund I want to warn you about is the DNP Select Income Fund (NYSE:DNP), a utility-focused CEF with a 9.9% annualized return over the last decade. It’s another well-run fund with a strong management team and a 7.1% dividend (paid monthly), so it’s no surprise that it has a lot of fans—too many, in fact.

A Big Premium Gets Bigger

This chart is different from those of the two PIMCO funds; DNP’s premium dipped moderately during the February-March selloff, only to spike, recede and rise again. This kind of erratic movement is particularly worrisome in light of the fund’s declining NAV and price return over the same period.

h3 No Big Performance for the Premium/h3

DNP’s portfolio has been hit not only by the pandemic but also by a general move away from utilities and into tech during the market’s recovery.

Sure, there’s a chance investors could swing back into utilities if there’s another pullback, but DNP’s massive premium still caps its upside, even if that were to happen. And if markets keep rising, a continued move into growth stocks could be especially harmful to DNP, given its high premium. Either way, the fund’s massive premium isn’t worth paying, no matter how well it has performed in the past.

h3 Just Released: 4 Bargain CEF Picks With 9.4% Dividends, 20%+ Upside/h3

Big dividends are great on their own, but if you have to buy an overpriced fund to get these high payouts, you’re taking a big risk.

That’s because a 9% dividend does you no good if the underlying share price collapses even more than that—a near-certainty if you buy a fund with an absurd 27%+ premium, like the one DNP sports now.

But remember when I said that there are still plenty of great CEF bargains to be had out there? Well, I’ve got 4 of the very best deals waiting for you now. They pay an outsized 9.4% average dividend—and, thanks to their massive discounts, I’m calling for 20%+ price upside in the next 12 months, even if the market only moves up slightly from here.

And if markets sell off?

These 4 funds’ big discounts will help stabilize their prices, automatically hedging our downside … and letting us enjoy these 9.4% dividends in peace!

Disclosure: Brett Owens and Michael Foster are contrarian income investors who look for undervalued stocks/funds across the U.S. markets. Click here to learn how to profit from their strategies in the latest report, "7 Great Dividend Growth Stocks for a Secure Retirement ."

Written By: Contrarian Outlook